3-Hour Virtual Seminar on FDA's Scrutiny of Social Media Promotion
View: 120
Website https://www.compliance4all.com/control/w_product/~product_id=502335LIVE?channel=ourglocal_Mar_2019_S |
Edit Freely
Category Marketing Directors, Quality Systems Auditors, Recall Managers
Deadline: March 11, 2019 | Date: March 12, 2019
Venue/Country: Online, U.S.A
Updated: 2019-01-21 15:06:10 (GMT+9)
Call For Papers - CFP
Overview:In this webinar you will Learn how to navigate through FDA requirements, Ways to manage your presence in social media, How to identify an off-label problem and corrective action.Why should you Attend:Limitations on commercial free speechAvenues of off-label informationSocial media and your regulatory responsibilitiesCorrecting off-label informationFactoring in cognitive psychologyAreas Covered in the Session:Learn to navigate through FDA requirementsUnderstand that your right to free speech is limitedHow to get around FDA prohibitionsWays to manage your presence in social mediaWho Will Benefit:Regulatory DirectorsMarketing DirectorsQuality Systems AuditorsRecall ManagersIn-house Legal CounselSpeaker Profile:Casper (Cap) Uldriks, through his firm “Encore Insight LLC,” brings over 32 years of experience from the FDA. He specialized in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health.Event Fee: One Dial-in One Attendee Price: US$290.00Contact Detail:Compliance4All DBA NetZealous,Phone: +1-800-447-9407Email: compliance4all14gmail.com
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.